Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Esperion Therapeutics Inc. News

    1,99 $ 0,00% +0,00 $
    In : 1,8560 € | 25.04.24 22:00:04 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1W1SJ
    ISIN: US29664W1053
    US-Symbol: ESPR
    Typ: Aktie

    Esperion Therapeutics Inc. News

    18.01.24 - PR Newswire
    Thinking about buying stock in Phoenix Motor, Mereo BioPharma, Esperion Therapeutics, Adagene, or Advanced Micro Devices?
    Thinking about buying stock in Phoenix Motor, Mereo BioPharma, Esperion Therapeutics, Adagene, or Advanced Micro Devices? PR Newswire
    09.01.24 - PR Newswire
    Thinking about buying stock in Grifols, Esperion Therapeutics, Rithm Capital, Applied Optoelectronics, or Seres Therapeutics?
    Thinking about buying stock in Grifols, Esperion Therapeutics, Rithm Capital, Applied Optoelectronics, or Seres Therapeutics? PR Newswire
    08.01.24 - PR Newswire
    Thinking about buying stock in Cyclacel Pharmaceuticals, Broadcom, Qualcomm, Esperion Therapeutics, or Arena Group?
    Thinking about buying stock in Cyclacel Pharmaceuticals, Broadcom, Qualcomm, Esperion Therapeutics, or Arena Group? PR Newswire
    05.01.24 - PR Newswire
    Thinking about buying stock in Safe & Green Development, Esperion Therapeutics, Ford Motor, Vertex Pharmaceuticals, or LifeMD?
    Thinking about buying stock in Safe & Green Development, Esperion Therapeutics, Ford Motor, Vertex Pharmaceuticals, or LifeMD? PR Newswire
    14.12.23 - PR Newswire
    Thinking about buying stock in Processa Pharmaceuticals, Adobe Inc, Progressive Corp, Hanryu Holdings, or Esperion Therapeutics?
    Thinking about buying stock in Processa Pharmaceuticals, Adobe Inc, Progressive Corp, Hanryu Holdings, or Esperion Therapeutics? PR Newswire
    26.09.23 - PR Newswire
    Thinking about buying stock in Pliant Therapeutics, Esperion Therapeutics, Murphy Canyon Acquisition Corp, Limbach Holdings, or Vaccitech?
    Thinking about buying stock in Pliant Therapeutics, Esperion Therapeutics, Murphy Canyon Acquisition Corp, Limbach Holdings, or Vaccitech? PR Newswire
    15.06.23 - PR Newswire
    Thinking about trading options or stock in Inpixon, DatChat, Esperion Therapeutics, Verastem, or Vision Marine Technologies?
    Thinking about trading options or stock in Inpixon, DatChat, Esperion Therapeutics, Verastem, or Vision Marine Technologies? PR Newswire
    15.06.22 - PR Newswire
    SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Esperion Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
    SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Esperion Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors PR Newswire
    10.03.22 - PR Newswire
    Thinking about buying stock in Marqeta, Ion Geophysical, Northern Dynasty Minerals, Esperion Therapeutics, or Aemetis?
    Thinking about buying stock in Marqeta, Ion Geophysical, Northern Dynasty Minerals, Esperion Therapeutics, or Aemetis? PR Newswire
    03.12.21 - PR Newswire
    Thinking about buying stock in DiDi Global, New Oriental Education, Longeveron, Carnival Corp, or Esperion Therapeutics?
    Thinking about buying stock in DiDi Global, New Oriental Education, Longeveron, Carnival Corp, or Esperion Therapeutics? PR Newswire
    01.02.21 - PR Newswire
    Thinking about trading options or stock in Nektar Therapeutics, Pfizer, AstraZeneca, Vir Biotechnology, or Esperion Therapeutics?
    Thinking about trading options or stock in Nektar Therapeutics, Pfizer, AstraZeneca, Vir Biotechnology, or Esperion Therapeutics? PR Newswire
    18.02.20 - PR Newswire
    Thinking about trading options or stock in Duke Energy, Esperion Therapeutics, Expedia, MSCI Inc, or Walmart?
    Thinking about trading options or stock in Duke Energy, Esperion Therapeutics, Expedia, MSCI Inc, or Walmart? PR Newswire
    24.04.19 - PR Newswire
    Moore Kuehn Encourages Esperion Therapeutics, Inc. Investors to Contact Law Firm for Possible Claims Against Officers and Directors
    Moore Kuehn Encourages Esperion Therapeutics, Inc. Investors to Contact Law Firm for Possible Claims Against Officers and Directors PR Newswire
    02.04.19 - PR Newswire
    Bempedoic Acid CLEAR Serenity Study Results Published in the JAHA Demonstrated Significant LDL-Cholesterol Lowering and Reduced hsCRP in Statin Intolerant Patients
    Bempedoic Acid CLEAR Serenity Study Results Published in the JAHA Demonstrated Significant LDL-​Cholesterol Lowering and Reduced hsCRP in Statin Intolerant Patients PR ...
    14.03.19 - PR Newswire
    Bempedoic Acid Study 1 Results Published in The New England Journal of Medicine Demonstrates Significant LDL-Cholesterol Lowering and Reduced Marker of Underlying Cardiovascular Inflammation, with a Similar Tolerability to Placebo
    Bempedoic Acid Study 1 Results Published in The New England Journal of Medicine Demonstrates Significant LDL-​Cholesterol Lowering and Reduced Marker of Underlying ...
    07.01.19 - PR Newswire
    Daiichi Sankyo Europe Enters into European Licensing Agreement with Esperion for Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet
    Daiichi Sankyo Europe Enters into European Licensing Agreement with Esperion for Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet PR Newswire
    05.06.18 - PR Newswire
    Lifshitz & Miller LLP Announces Investigation of ACETO Corporation, Esperion Therapeutics, Inc., Flex Ltd., Kulicke and Soffa Industries, Inc., Macquarie Infrastructure Corporation, Mercury System
    Lifshitz & Miller LLP Announces Investigation of ACETO Corporation, Esperion Therapeutics, Inc., Flex Ltd., Kulicke and Soffa Industries, Inc., Macquarie Infrastructure Corporation, ...
    02.05.18 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Esperion Therapeutics, Inc. - ESPR
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Esperion Therapeutics, Inc. - ESPR PR Newswire
    02.05.18 - PR Newswire
    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Esperion Therapeutics, Inc. (ESPR)
    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Esperion Therapeutics, Inc. (ESPR) PR Newswire
    14.03.18 - The Motley Fool
    Regeneron zielt auf Amgen und Esperion Therapeutics ab
    Fast ein Jahr nachdem der Wettbewerber Amgen (WKN:867900) gemeldet hatte, dass das cholesterinsenkende Medikament Repatha das Risiko von schweren unerwünschten ...

    Newssuche

    Videos

    newspaper
    25.04.24 +21,95%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »